25-09-15 DiaMonTech AG announced that it has received ?8 million in funding from Samsung NEXT, LLC CI
24-11-25 DiaMonTech AG announced that it has received funding from Disrupt Health Impact Fund CI
23-12-06 DiaMonTech AG announced that it has received funding from Moll Family GmbH, and other investors CI
22-02-16 DiaMonTech AG announced that it has received $5 million in funding from IBB Beteiligungsgesellschaft mbH, Unorthodox Ventures, Samsung Venture Investment Corporation CI
19-11-26 DiaMonTech AG has withdrawn its IPO in the amount of €59.375 million. CI
19-11-25 DAK-Gesundheit and DiaMonTech AG Plan Strategic Cooperation in the Non-Invasive Blood Glucose Monitoring Sector for New Treatment Strategies in the Diabetes Sector CI
19-11-13 DiaMonTech AG has filed an IPO in the amount of €59.375 million. CI
19-11-11 DiaMonTech AG Signs A Further Agreement with an International Sales Company CI
19-10-21 DiaMonTech GmbH Publishes Results of Clinical Study Confirming the Accuracy of its Non-Invasive Blood Glucose-Monitoring Technology CI
19-10-01 DiaMonTech GmbH Appoints Enrico Just as Managing Director and CFO CI
19-09-16 Deutscher Apothekerverband e. V. & DiaMonTech GmbH Intends Strategic Cooperation to Significantly Improve the Care of Diabetes Patients and to Take an Innovative Step into the Future CI
19-09-08 DiaMonTech GmbH announced that it has received €7 million in funding from IBB Beteiligungsgesellschaft mbH, Bioventure Consulting GmbH, and other investors CI
18-09-04 DiaMonTech GmbH announced that it has received funding from IBB Beteiligungsgesellschaft mbH, Macnica, Inc., Jindong Investment Group Co., Ltd. CI
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 2015-01-09
Chief Executive Officer 52 2015-03-31
Director of Finance/CFO - 2019-09-30
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 0
+33.67%+54.23% - - 1.27B
+3.16%+1.56%-35.54%-40.49% 666M
+0.40%-9.77%+67.11% - 327M
+0.40%-2.19%-37.36%-21.65% 128M
0.00%-13.04%-29.96%+20.00% 69.84M
Average +6.27%+6.48%-8.94%-14.05% 492.34M
Weighted average by Cap. +18.30%+26.93%-7.19%-32.81%
Logo DiaMonTech AG
DiaMonTech AG is a Germany-based medical device company. It develops a device for non-invasive measuring of glucose levels in diabetes patients. The device is based on spectroscopy and uses photothermal detection technology. The device range under development includes a desktop device for clinical settings and multiple users, as well as a compact pocket device for the end user.
Employees
-